MedTrace Logo

iBeat Wristwatch Validation Study

NCT03711695 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2019-03-05

No results posted yet for this study

Summary

The iBeat Study is a single-center, prospective, unblinded validation of the photoplethysmography (PPG) and tissue oximetry (TO) signal waveforms recorded from a wrist-based sensor devices.

Conditions

  • Arrythmia, Cardiac

Interventions

DEVICE

iBeat wristwatch device

The participant will be asked to wear one iBeat wristwatch device on each arm during the planned procedure.

Sponsors & Collaborators

Principal Investigators

  • Jeffrey Olgin, MD · University of California, San Francisco

  • Robert Avram, MD · University of California, San Francisco

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-22
Primary Completion
2018-12-30
Completion
2018-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03711695 on ClinicalTrials.gov